@article{95f6247bcdca4292babefc626b7d9041,
title = "Reply to 'Therapeutic drug monitoring for isoniazid and rifampicin exposure'",
keywords = "Humans, Isoniazid/adverse effects, Rifampin/adverse effects, Drug Monitoring, Antitubercular Agents/adverse effects, Mycobacterium tuberculosis",
author = "Akkerman, \{O W\} and Kerstjens, \{H A M\} and M Kingma and Bolhuis, \{M S\} and Sturkenboom, \{M G G\}",
year = "2024",
month = mar,
day = "1",
doi = "10.5588/ijtld.24.0022",
language = "English",
volume = "28",
pages = "169--170",
journal = "The International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "3",
}